MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Transient mild hyperglycemia as diagnostic tool for idiopatic Parkinson’s disease triggered by psychoemotional stress

    M.N. Khanova, K.A. Rasulova (Tashkent, Uzbekistan)

    Objective: We studied clinical features and the levels of glucose in blood of patients with idiopathic PD (IPD) of different sages and duration who had…
  • 2016 International Congress

    Carrier mediated delivery system bearing dopamine for effective management of parkinsonism

    V. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposome bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2016 International Congress

    Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism

    F. Krismer, B. Pinter, C. Müller, P. Mahlknecht, M. Nocker, E. Reiter, A. Djamshidian-Tehrani, S.M. Bösch, G.K. Wenning, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…
  • 2016 International Congress

    Zolpidem ameliorates the freezing of gait in a patient with PAGF (pure akinesia with freezing of gait)-the possible neural mechanism

    C.H. Tsai, H.C. Huang, J.R. Duann, B.L. Liu, H.C. Lin, M.K. Lu, J.C. Chen (Taichung, Taiwan)

    Objective: To investigate the possible mechanism of amelioration of freezing of gait (FOG) in a patient with PAGF (Pure Akinesia with Freezing of Gait) by…
  • 2016 International Congress

    Comparative analysis of freezing of gait in distinct parkinsonism types by diffusion tensor imagining and cognitive profiles

    H. Onder, E.S. Topcuoglu, A.C. Has, K.K. Oguz, B. Elibol (Ankara, Turkey)

    Objective: To demonstrate possible disturbances in pedinculopontine nucleus (PPN) and its connections in freezing of gait (FOG) by DTI in conjunction with the cognitive profile.…
  • 2016 International Congress

    Swallowing in individuals with Parkinson’s disease: A study of FEES

    A. Ayres, M.R. Olchik, C.R.M. Rieder, G.P. Jotz (Porto Alegre, Brazil)

    Objective: To characterize the pattern of swallowing in individuals with Parkinson's disease (PD) through functional endoscopic evaluation of swallowing (FEES). Background: Dysphagia is a highly…
  • 2016 International Congress

    Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life

    M. Chraa, K. Choulli, N. Kissani (Marrakech, Morocco)

    Objective: To highlight the frequency of non motor symptoms in patients with Parkinson's disease and to evaluate their impact on quality of life. Background: Parkinson's…
  • 2016 International Congress

    Clinical profile of Parkinson’s disease at the neurology department of Point G Teaching Hospital

    T. Coulibaly, A.S. Sissoko, T. Coulibaly, L. Guida, K. Mamadou, G.C. Oumar (Bamako, Mali)

    Objective: To determine the frequency and clinical features of PD at the neurology department of Point G Teaching Hospital. Background: PD results from loss of…
  • 2016 International Congress

    Frequency and factors associated with neuropathic pain in patients with Parkinson’s disease

    J.F. Pascacio-Astudillo, A.L. Bazàn-Rodrìguez, M. Rodrìguez-Violante, A. Cervantes-Arriaga (Mèxico City, Mexico)

    Objective: To determine the prevalence of neuropathic pain in PD and association between neuropathic pain, duration of PD, treatment with Levodopa, cumulative dose, non-motor symptoms…
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • « Previous Page
  • 1
  • …
  • 360
  • 361
  • 362
  • 363
  • 364
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley